HCV-IN-3 is primarily utilized in the research and development of antiviral therapies, specifically targeting the hepatitis C virus (HCV). It functions as an inhibitor, designed to interfere with the viral replication process, thereby reducing the viral load in infected individuals. This compound is often employed in preclinical studies to evaluate its efficacy and safety profile. Researchers use it to understand the mechanisms of viral inhibition and to explore potential therapeutic strategies. Its application is crucial in the ongoing efforts to develop more effective treatments for HCV, contributing to advancements in antiviral drug discovery and the fight against hepatitis C-related diseases.